G-Protein Coupled Receptors Market forecast
Orphan GPCRs—receptors whose natural ligands are not yet identified—represent a promising frontier in the G-Protein Coupled Receptors Market. These receptors offer untapped therapeutic opportunities, particularly in neurological, metabolic, and immune disorders.
By targeting orphan GPCRs, researchers aim to develop drugs for conditions that currently have limited treatment options. For instance, certain orphan receptors regulate appetite, pain, or cardiovascular functions, making them attractive targets for new medications. The discovery of ligands for these receptors can lead to innovative therapies with higher efficacy and fewer side effects.
Investments in high-throughput screening, AI-driven ligand prediction, and structural biology accelerate orphan GPCR research. Global companies are increasingly collaborating with research institutes to explore these novel targets, expanding the scope of the GPCR market.